You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 16, 2024

CLINICAL TRIALS PROFILE FOR XELJANZ

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for XELJANZ

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01932372 ↗	Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis	Completed	Pfizer		2013-07-26	The objective of this Surveillance is to verify the following subject matters concerning Tofacitinib (Xeljanz) under general practice. 1) Occurrence of adverse reactions, factors that may potentially affect safety and efficacy 2） Long-term safety (particularly, malignant tumors and serious infections) and efficacy Occurrences of malignant tumors and serious infections will be compared with a control group.
NCT02157012 ↗	Evaluation of the Condition of Rheumatoid Arthritis After Treatment	Recruiting	Showa Inan General Hospital	Phase 4	2014-05-01	To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
NCT02157012 ↗	Evaluation of the Condition of Rheumatoid Arthritis After Treatment	Recruiting	Shinshu University	Phase 4	2014-05-01	To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for XELJANZ

Condition Name

Chart
Table

Condition Name for XELJANZ
Intervention	Trials
Rheumatoid Arthritis	9
Alopecia Areata	4
Psoriatic Arthritis	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for XELJANZ
Intervention	Trials
Arthritis	12
Arthritis, Rheumatoid	9
Alopecia Areata	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for XELJANZ

Trials by Country

Map
Table

Trials by Country for XELJANZ
Location	Trials
United States	36
Mexico	6
China	6
Spain	5
Canada	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for XELJANZ
Location	Trials
California	4
Ohio	3
Pennsylvania	3
Florida	3
New York	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for XELJANZ

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for XELJANZ
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	4
Phase 2	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for XELJANZ
Clinical Trial Phase	Trials
Recruiting	14
Completed	9
Not yet recruiting	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for XELJANZ

Sponsor Name

Chart
Table

Sponsor Name for XELJANZ
Sponsor	Trials
Pfizer	9
University of Nebraska	2
Stanford University	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for XELJANZ
Sponsor	Trials
Other	38
Industry	18
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.